McDonald Partners’s Globus Medical GMED Stock Holding History

McDonald Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20	Closed	-$1.44K	–	464
2021 Q4	$1.44K	Buy	+20	New	+$1.45K	﹤0.01%	403

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

McDonald Partners's GMED Position: Q1 2022 in Review

McDonald Partners sold out of Globus Medical (GMED) in Q1 2022, closing a stake of 20 shares — an estimated $1.44K sold.

McDonald Partners first reported a position in GMED in Q4 2021 and held it in 1 quarter. The position peaked at $1.44K in Q4 2021. 377 funds tracked by Wall St. Rank hold GMED as of Q1 2022.

McDonald Partners reported no remaining Globus Medical position as of Q1 2022 after selling out during the quarter.
McDonald Partners sold 20 Globus Medical shares in Q1 2022, an estimated $1.44K.
McDonald Partners first reported a position in Globus Medical in Q4 2021 and held it in 1 quarter.
McDonald Partners's Globus Medical position peaked at $1.44K in Q4 2021.
377 funds tracked by Wall St. Rank held Globus Medical as of Q1 2022.

Based on McDonald Partners's 13F filing for Q1 2022, filed 29 Apr 2022.